Amarin Pharma News Today

This week has seen mining company Lavras Gold appoint Naomi Nemeth to vice president of investor relations and

Matthew Cullen Joins as Vice President of Value and Access Lisa DeFrancesco Joins as Head of Investor Relations and Corporate Strategy THE WOODLANDS, Texas, Oct. 31, 2023 -- Lexicon...

On October 23, the U.S. Food and Drug Administration (FDA or Agency) released a much anticipated draft guidance entitled...

The period following the filing of a section 337 complaint with the U.S. International Trade Commission (ITC) can be chaotic.... All section 337 litigants confront a series of strategic decisions that can send them on the path to success or failure in the investigation.

Rising healthcare and well-being expenditure along with surging demand from athletes to drive global Omega-3 Market growth, particularly in North America....

In recent decades, U.S. and foreign biopharmaceutical companies (makers of drugs that are based on chemical compounds or biological materials, such as vaccines) and medical device manufacturers have been responsible for many cures and advances in treatment that have benefited patients’ lives. New cancer treatments, medical devices, and other medical discoveries are being made at a rapid pace.

‘Reprioritization’ seen in the marketing mix as the industry finds a new post-COVID equilibrium.

NAD Won’t Rename Supplement Maker - Innovix Pharma loses on product claims but gets to keep its calling card. Nerding Out - Aside from the in...

/PRNewswire/ -- The National Advertising Division (NAD) of BBB National Programs determined that Innovix Pharma Inc., manufacturer of OmegaVia Fish Oil and...

NEW YORK, April 26, 2022 /PRNewswire/ -- The National Advertising Division (NAD) of BBB National Programs determined that Innovix Pharma Inc., man...